exercise programs for clients taking glp-1 medications and Strength Training: What You Need to Know Train With Dave Offers Strength

A new plan to lower the price of GLP-1s The Trump administration announced in early November that it had struck a deal with leading GLP-1 pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, to lower consumer prices for GLP-1 medications

Prejudice against fat people: ideology and self-interest

GLP-1 drugs consumer acceptance is changing rapidly

Nationwide retrospective studies utilizing register data from Sweden and Denmark (20132021) and the UK CPRD (20072020) have revealed consistent findings, indicating that GLP-1 RAs are not associated with an elevated risk of suicidality relative to DPP-4 or SGLT-2 inhibitors [77,78]